Atlas Trials

Vaccination With Lethally Irradiated Glioma Cells Mixed With GM-K562 Cells in Patients Undergoing Craniotomy For Recurrent Tumor

Clinical trial NCT00694330 · COMPLETED

Trial details

NCT number
NCT00694330
Sponsor
Massachusetts General Hospital
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Glioma
Start date
2008-06-01
Primary completion
2009-08-01
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.